Faculty

Institution

Unit

Venue

Ruth Keri

Professor Vice Chair

Case Western Reserve University

Affiliations

School of Medicine

Pharmacology

Ruth Keri is currently serving as a Pharmacology Professor Vice Chair at Case Western Reserve University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ruth Keri

Case Western Reserve University

Professor Vice Chair

You can click a keyword to filter the displayed items

breast cancer oncology cancer biology cancer research genetics molecular biology pharmacology tumor biology cell biology medicinal research endocrinology gene expression oncogenes mammalian biology cancer genetics breast oncology molecular cancer cancer treatment cancer cells cancer genomics cancer care tumor targeting cell signaling reproductive biology enzyme inhibition biological chemistry genome biology cell regulation anti-cancer agents cellular therapy endocrine research endocrine oncology transgenic mice molecular cell biology gene function redox biology gene regulation drug targeting membrane biology molecular physiology cell death transcription regulation molecular regulation reproductive physiology mammary gland cancer growth tumor suppressors triple-negative breast cancer protein expression animal biotechnology rna biology nanobiotechnology human reproduction chromosome biology cytogenetics endocrine mechanisms animal reproduction spatial transcriptomics respiratory toxicology pituitary gland medical genetics comparative endocrinology genome instability mouse model preneoplastic breast microenvironment proximal promoter chromosomal instability comprehensive characterization current levels carcinogenic potential carcinogenic activity essential determinant era expression mammary ductal morphogenesis disease mutations protein-protein interactions

Notable Scholarly Works

Notable Federal Grants

Collaborators

Integrated Collagen Architecture and Composition Improve Risk Stratification in Triple-Negative Breast Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2026)

biomedical researchbiomedical engineeringmatrix biologybiomaterialsbreast cancercell-matrix interactionstumor microenvironment

Mo1326 Spatial Transcriptomics Reveal Reduced Expression of Metallothioneins in Polyps and Colon Cancer in Pten Hamartoma Tumor Syndrome. Gastroenterology (2026)

carcinogenesismolecular cancertumor suppressorsmolecular biologypathologycell biology

Supplementary Fig. 6 From Targeting the Erα Dbd–Lbd Interface With Mitoxantrone Disrupts Receptor Function Through Proteasomal Degradation. (2026)

enzyme inhibitionpharmacologymechanisms of actiontherapeutic targetsdrug discoverybiochemistry

Abstract Lb077: Identifying Therapeutic Vulnerabilities in Lobular Breast Cancer. Cancer Research (2025)

cancer lettersystems biologybreast cancerbreast oncology

Abstract P2-04-05: The Dynein Regulator Lis1 Maintains Cell Cycle Progression and Dna Integrity in Tnbc, and Can Be Targeted to Improve Paclitaxel Response. Clinical Cancer Research (2025)

cell cycletherapeutic targetsmolecular biologyoncogenescancer cellstumor biologycell biology

Abstract P5-04-27: A Novel Patient-Derived Xenograft Model of Inflammatory Breast Cancer. Clinical Cancer Research (2025)

cancer discoverybreast cancercancer biologypathologytumor biologycell biology

Cancer Burden in Neighborhoods With Greater Racial Diversity and Environmental Burden. JAMA Network Open (2025)

public healthhealth equityhealth disparitiescancer carecancer researchsocial determinants of healthurban healthcancer disparities

Figure S7 From Exploiting Yes1-Driven Egfr Expression Improves the Efficacy of Egfr Inhibitors. (2025)

pharmacologycell signalingmolecular cancerreceptor tyrosine kinasestherapeutic targetsoncogenescell biology

Materials and Methods From Exploiting Yes1-Driven Egfr Expression Improves the Efficacy of Egfr Inhibitors. (2025)

tumor targetingoncogenestherapeutic targetscell biology

Mitoxantrone Inhibits and Downregulates Er α Through Binding at the Dbd-Lbd Interface. bioRxiv (Cold Spring Harbor Laboratory) (2025)

Han WangYuxuan LuoSandeep ArthamQianqian WangYi PengZixi YunXinyue LiChen WuZhenghao LiuKristen L. Weber-BonkChun-Peng PaiYuan CaoJiangan YueSunghee ParkRuth A. KeriLisheng GengDonald P. McDonnellHung-Ying KaoSichun Yang

mechanisms of actioncell signalingmolecular pharmacologybiochemistryproteinlipid interactionchemical biologyprotein sciencemitoxantrone inhibitsredox signalingbiochemical interactiongene expressionbiophysicsenzyme inhibitionpsychopharmacologyfree radical biologyredox biologymolecular biologydbd-lbd interfacemedicinal researchoxidative stress

1
2
3
4
5
20
10 / page

Ruth Keri

Professor Vice Chair

Case Western Reserve University

Affiliations

School of Medicine

Pharmacology

Ruth Keri is currently serving as a Pharmacology Professor Vice Chair at Case Western Reserve University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ruth Keri

Case Western Reserve University

Professor Vice Chair

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Integrated Collagen Architecture and Composition Improve Risk Stratification in Triple-Negative Breast Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2026)

biomedical researchbiomedical engineeringmatrix biologybiomaterialsbreast cancercell-matrix interactionstumor microenvironment

Mo1326 Spatial Transcriptomics Reveal Reduced Expression of Metallothioneins in Polyps and Colon Cancer in Pten Hamartoma Tumor Syndrome. Gastroenterology (2026)

carcinogenesismolecular cancertumor suppressorsmolecular biologypathologycell biology

Supplementary Fig. 6 From Targeting the Erα Dbd–Lbd Interface With Mitoxantrone Disrupts Receptor Function Through Proteasomal Degradation. (2026)

enzyme inhibitionpharmacologymechanisms of actiontherapeutic targetsdrug discoverybiochemistry

Abstract Lb077: Identifying Therapeutic Vulnerabilities in Lobular Breast Cancer. Cancer Research (2025)

cancer lettersystems biologybreast cancerbreast oncology

Abstract P2-04-05: The Dynein Regulator Lis1 Maintains Cell Cycle Progression and Dna Integrity in Tnbc, and Can Be Targeted to Improve Paclitaxel Response. Clinical Cancer Research (2025)

cell cycletherapeutic targetsmolecular biologyoncogenescancer cellstumor biologycell biology

Abstract P5-04-27: A Novel Patient-Derived Xenograft Model of Inflammatory Breast Cancer. Clinical Cancer Research (2025)

cancer discoverybreast cancercancer biologypathologytumor biologycell biology

Cancer Burden in Neighborhoods With Greater Racial Diversity and Environmental Burden. JAMA Network Open (2025)

public healthhealth equityhealth disparitiescancer carecancer researchsocial determinants of healthurban healthcancer disparities

Figure S7 From Exploiting Yes1-Driven Egfr Expression Improves the Efficacy of Egfr Inhibitors. (2025)

pharmacologycell signalingmolecular cancerreceptor tyrosine kinasestherapeutic targetsoncogenescell biology

Materials and Methods From Exploiting Yes1-Driven Egfr Expression Improves the Efficacy of Egfr Inhibitors. (2025)

tumor targetingoncogenestherapeutic targetscell biology

Mitoxantrone Inhibits and Downregulates Er α Through Binding at the Dbd-Lbd Interface. bioRxiv (Cold Spring Harbor Laboratory) (2025)

1
2
3
4
5
20
10 / page

Similar Faculty Members

Donald McDonnell

Institution

Duke University

pharmacology

endocrinology

Justin D. Lathia

Institution

Case Western Reserve University

oncology

brain tumor research

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Patricia K. Donahoe

Institution

Harvard University

developmental system

developmental endocrinology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Paul C. Boutros

Institution

University of California, Los Angeles

biomedical data science

biomedical informatics

Hui Li

Institution

University of Virginia

cell biology

oncogenes

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Similar Faculty Members

Donald McDonnell

Institution

Duke University

pharmacology

endocrinology

Justin D. Lathia

Institution

Case Western Reserve University

oncology

brain tumor research

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Patricia K. Donahoe

Institution

Harvard University

developmental system

developmental endocrinology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Paul C. Boutros

Institution

University of California, Los Angeles

biomedical data science

biomedical informatics

Hui Li

Institution

University of Virginia

cell biology

oncogenes

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene